It looks like you are visiting CMR Surgical from the United States of America.
Please select the following:

I am a US healthcare professional practicing in the United States of America I am NOT a US healthcare professional practicing in the United States of America
May 14, 2018
CMR Surgical receives extension to ISO 13485:2012 certification
May 14, 2018
CMR Surgical receives extension to ISO 13485:2012 certification

Cambridge, UK, 14 May 2018 | CMR Surgical, the British company developing a next-generation surgical robot, has received an extension to its ISO certification to cover manufacturing, installation and service. ISO 13485 is a globally recognised standard for quality management systems, which supports the design and manufacture of medical devices.

Press Office

T: +44 01223 755801

CMR Surgical has more than doubled in size in the past year. It now employs over 200 people and expects to continue its significant growth as it moves closer to submitting its surgical robotic system, Versius, for regulatory approval.

Martin Frost, CMR’s Chief Executive Officer, said: “Receiving the ISO extension is testament to how CMR Surgical is rapidly gearing up to become a significant British medical devices company that designs, develops and manufactures some of the most advanced medical technology here in the UK.”

Versius is a surgical robot designed to meet the complex requirements of laparoscopic surgery. It is inspired by the human arm and has remarkable dexterity, flexibility and reach, enabling a new paradigm in surgical experience – driving CMR Surgical’s vision in making minimal access surgery available to all.


About CMR Surgical

CMR Surgical is a British private limited company developing the next-generation universal robotic system, Versius®, for minimal access surgery.

The vision behind CMR Surgical is to make minimal access surgery universally accessible and affordable, transforming the existing market for surgical robotics while also addressing the six million people who still undergo open surgery each year.

Global annual revenues for robot-assisted minimal access surgery are presently approximately $4 billion and are anticipated to reach $20 billion by 2025.1

CMR Surgical, formed in 2014, has its headquarters in Cambridge, United Kingdom and is backed by an international shareholder base of specialist and generalist investors. The Company achieved the registration of its Quality Management System to ISO 13485:2003 and ISO 13485:2012 by Underwriters Laboratories LLC® (‘UL’), and the status as a UL Registered Firm, in September 2015.

For further information, please visit

About Versius, the CMR Surgical robotic system

Designed to meet the complex requirements of laparoscopic surgery, Versius’ compact size fits easily into the existing surgical workflow, while its ergonomic console design allows surgeons to work in a way that reduces physical and mental effort.  Intended to be used across a range of surgical specialties, the versatility and portability of Versius, enabled by a unique and patented four-axis wrist joint, expands the potential for higher utilisation. The versatility of the system and compelling commercial model allows healthcare providers to offer the benefits of robotic-assisted procedures in a cost-effective way.

1 Industry Forecast, Accuray Research